BetterLife Pharma (BETRF) Operating Expenses (2010 - 2026)
BetterLife Pharma (BETRF) posted quarterly Operating Expenses of $426847.8 for Q2 2026, up 95.51% year-over-year from $218325.9 in Q2 2025, and up 12.4% quarter-over-quarter from $379762.0 in Q3 2025.
BetterLife Pharma (BETRF) Operating Expenses (2010 - 2026) Analysis & Trends
BetterLife Pharma's Operating Expenses history runs 17 years deep, the most recent figure standing at $426847.8 for Q2 2026.
- In Q2 2026, Operating Expenses rose 95.51% year-over-year to $426847.8; the TTM figure through Apr 2026 stood at $1.0 million (down 52.45% YoY), while the FY2026 annual figure was $1.2 million, down 67.11% from the prior year.
- Operating Expenses for Q2 2026 stood at $426847.8, up from $379762.0 in the prior quarter.
- The five-year high for Operating Expenses was $3.4 million in Q4 2022, with the low at $218325.9 in Q2 2025.
- The 5-year median for Operating Expenses is $625082.1 (2023), against an average of $1.0 million.
- The sharpest annual moves came in 2024 and 2025: Operating Expenses surged 176.95% in 2024, then sank 87.25% in 2025.
- BetterLife Pharma's Operating Expenses stood at $3.4 million in 2022, then tumbled by 81.54% to $631648.0 in 2023, then declined by 13.21% to $548219.9 in 2024, then sank by 30.73% to $379762.0 in 2025, then grew by 12.4% to $426847.8 in 2026.
- Business Quant data shows BETRF's Operating Expenses at $426847.8 in Q2 2026, $379762.0 in Q3 2025, and $218325.9 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | BetterLife Pharma | 40.15 Mn | 42.53 Mn | - | 33,367.61 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 426,847.83 |
| Jul 31, 2025 | 379,762.02 |
| Apr 30, 2025 | 218,325.86 |
| Jan 31, 2025 | 535,410.90 |
| Oct 31, 2024 | 548,219.88 |
| Jul 31, 2024 | 853,557.23 |
| Apr 30, 2024 | 1.71 Mn |
| Jan 31, 2024 | 458,536.33 |
| Oct 31, 2023 | 631,648.03 |
| Jul 31, 2023 | 694,494.70 |
| Apr 30, 2023 | 618,516.17 |
| Jan 31, 2023 | 467,543.34 |
| Oct 31, 2022 | 3.42 Mn |
| Jul 31, 2022 | 957,699.60 |
| Apr 30, 2022 | 2.41 Mn |
| Jan 31, 2022 | 1.78 Mn |
| Oct 31, 2021 | 1.70 Mn |
| Jul 31, 2021 | 2.73 Mn |
| Apr 30, 2021 | 1.95 Mn |
| Jan 31, 2021 | 1.73 Mn |